Your browser doesn't support javascript.
loading
Megacolon tóxico en paciente con COVID-19 / Toxic megacolon in a patient with Covid-19
Ortega Rosales, Alberto; Romero Ulloa, Gilda; Burneo Rosales, Carlos.
Affiliation
  • Ortega Rosales, Alberto; Hospital General Marco Vinicio Iza. Nueva Loja. EC
  • Romero Ulloa, Gilda; Hospital General Marco Vinicio Iza. Nueva Loja. EC
  • Burneo Rosales, Carlos; Hospital General Marco Vinicio Iza. Nueva Loja. EC
Rev. cuba. med ; 60(supl.1): e2484, 2021. graf
Article in Spanish | LILACS, CUMED | ID: biblio-1408965
Responsible library: CU1.1
RESUMEN

Introducción:

La pandemia derivada de la enfermedad por el nuevo coronavirus 2019 (COVID-19) se ha convertido en una emergencia de salud pública mundial, debido a que puede desarrollar complicaciones que amenazan la vida. Si bien se sabe que el SARS-CoV-2 causa enfermedad pulmonar sustancial, se han observado muchas manifestaciones extrapulmonares, incluyendo el compromiso del sistema gastrointestinal. El megacolon tóxico es una complicación rara pero, potencialmente, mortal que se asocia más con la enfermedad inflamatoria intestinal. Sin embargo, cualquier afección que conduzca a la inflamación del colon puede conducir a una dilatación tóxica.

Objetivo:

Se presenta el caso de un paciente con un síndrome de dificultad respiratoria aguda secundario a una infección por SARS-COV-2. De manera concomitante presentó un cuadro de dilatación no obstructiva del colon, asociado con toxicidad sistémica. Caso clínico El desarrollo de megacolon tóxico en un paciente con SARS-COV-2 puede estar justificado debido a que el virus infecta las células huésped a través del receptor de la enzima convertidora de angiotensina 2. Se cumplieron los criterios diagnósticos para megacolon tóxico.

Conclusiones:

Esta también se encuentra altamente expresada en las células epiteliales intestinales, por lo tanto, se debe considerar su diagnóstico oportuno para una intervención temprana, en aras de reducir la tasa de mortalidad tanto como sea posible(AU)
ABSTRACT

Introduction:

The pandemic derived from the 2019 novel coronavirus disease (COVID-19) has become a global public health emergency, due to the fact that it can develop life-threatening complications. Although SARS-CoV-2 is known to cause substantial lung disease, many extra-pulmonary manifestations have been observed, including involvement of the gastrointestinal system. Toxic mega colon is a rare but life-threatening complication most associated with inflammatory bowel disease. However, any condition that leads to inflammation of the colon can lead to toxic dilation.

Objective:

To report the case of a patient with ARDS secondary to a SARS-COV-2 infection. Concomitantly, she had non-obstructive dilation of the colon, associated with systemic toxicity. Clinical case report The development of toxic mega colon in a patient with SARS-COV-2 may be justified because the virus infects host cells through the angiotensin-converting enzyme 2 receptor. The diagnostic criteria for toxic megacolon were met.

Conclusions:

It is also highly expressed in intestinal epithelial cells, therefore, its timely diagnosis should be considered for early intervention, in order to reduce the mortality rate as much as possible(AU)
Subject(s)

Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being / Neglected Diseases / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Diarrhea / COVID-19 / Diarrhoeal Infections / Pneumonia / Other Respiratory Diseases Database: CUMED / LILACS Main subject: Gastrointestinal Diseases / Angiotensin-Converting Enzyme 2 / COVID-19 / Megacolon, Toxic Limits: Humans Country/Region as subject: South America / Ecuador Language: Spanish Journal: Rev. cuba. med Journal subject: Medicine Year: 2021 Document type: Article Affiliation country: Ecuador Institution/Affiliation country: Hospital General Marco Vinicio Iza/EC
Full text: Available Collection: International databases Health context: SDG3 - Health and Well-Being / Neglected Diseases / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Target 3.4: Reduce premature mortality due to noncommunicable diseases / Diarrhea / COVID-19 / Diarrhoeal Infections / Pneumonia / Other Respiratory Diseases Database: CUMED / LILACS Main subject: Gastrointestinal Diseases / Angiotensin-Converting Enzyme 2 / COVID-19 / Megacolon, Toxic Limits: Humans Country/Region as subject: South America / Ecuador Language: Spanish Journal: Rev. cuba. med Journal subject: Medicine Year: 2021 Document type: Article Affiliation country: Ecuador Institution/Affiliation country: Hospital General Marco Vinicio Iza/EC
...